IVF After 40: Real Success Rates & Tips

Let's start with an uncomfortable truth that too many fertility websites either sugarcoat or ignore entirely: after 40, IVF success rates with your own eggs decline significantly. That's the biology, and no amount of positive thinking changes it.

But here's the part those same websites also miss: "lower success rates" does not mean "no success." Thousands of women over 40 have successful IVF pregnancies every year. The question isn't whether it's possible - it clearly is. The question is: what do you need to know, do, and decide to give yourself the best possible chance?

This guide is written for women and couples who want data, not platitudes. Who want realistic expectations paired with actionable strategies. Who deserve to make this decision with complete information.

What Are IVF Success Rates by Age After 40?

These figures represent clinical pregnancy rates per embryo transfer cycle using own eggs, based on aggregated data from the Society for Assisted Reproductive Technology (SART) and European Society of Human Reproduction and Embryology (ESHRE):

• Age 40: 20-25% per cycle
• Age 41: 15-20% per cycle
• Age 42: 10-15% per cycle
• Age 43: 5-10% per cycle
• Age 44+: Under 5% per cycle (with own eggs)

Important context: these are per-cycle rates. Cumulative success over multiple cycles is substantially higher. A woman at 40 who undergoes three IVF cycles has a cumulative live birth probability of approximately 35-45% - a very different picture from the 20-25% single-cycle figure.

Why Does Age Matter So Much?

The decline isn't about overall health or fitness. A 42-year-old marathon runner faces the same age-related fertility decline as a 42-year-old who doesn't exercise. The critical factor is egg quality - specifically, the rate of chromosomal abnormalities (aneuploidy) in eggs.

• At age 30: approximately 30% of eggs are aneuploid
• At age 37: approximately 45% are aneuploid
• At age 40: approximately 60% are aneuploid
• At age 43: approximately 80-85% are aneuploid

Aneuploid embryos either fail to implant, result in early miscarriage, or - rarely - lead to chromosomal conditions. This is why PGT-A genetic screening becomes increasingly valuable after 40, as supported by ASRM guidelines: by identifying the chromosomally normal embryos in your cohort, it eliminates the "wasted" transfer cycles on embryos that were never going to succeed.

How Should You Read a Clinic's Success Rates?

The figures above come from national registries, which is why they are worth taking seriously. A clinic's own figures deserve more scrutiny — not because clinics are dishonest, but because a success rate is a construction, and how it is built changes what it says.

Ask what the denominator is. A rate measured per embryo transfer excludes everyone whose cycle was cancelled or who had no embryo to transfer — which, past forty, is a meaningful group. Per cycle started is the harder and more honest measure. Ask about the numerator too: a clinical pregnancy is not a live birth, and the gap between the two widens with age.

Then ask who is counted. A clinic that declines patients with a poor prognosis will publish better numbers than one accepting them, without being better at treating anyone. And check the age bands: "over forty" as a single bracket blends a wide range of prognoses into one figure that describes almost nobody.

The figure that matters is the one for people with your age, your ovarian reserve, and your diagnosis, at that clinic. Ask for it directly — a team that will not answer straight has told you something useful anyway.

Which Tests Build Your Personal Picture?

Age is a population statistic. Your own prognosis depends on where you sit within your age band — and a handful of tests are what locate you. Knowing what each test does not tell you matters just as much.

• AMH (Anti-Müllerian Hormone): estimates how many eggs remain and predicts how you are likely to respond to stimulation. It says nothing about the quality of those eggs, and a low result on its own is not a verdict.
• Antral follicle count: an ultrasound count that complements AMH. Together they shape your protocol more than either does alone.
• FSH and oestradiol: read together, early in the cycle. These fluctuate, so a single reading is a snapshot rather than a trend.
• Assessment of the uterus and lining: ultrasound and, where indicated, hysteroscopy. The uterus ages differently from the ovaries, and a treatable finding here is far better known before a transfer than after one.
• Your partner's semen analysis: non-negotiable. Male factor does not disappear because the conversation has been about your age.

None of these predicts the outcome of a cycle. What they do is turn a general prognosis into a specific one, and let your specialist build a protocol around your biology rather than around an average.

How Can You Improve IVF Success After 40?

You can't change your eggs' chronological age. But you can optimize the environment in which those eggs develop, the technology used to assess them, and the clinical protocols applied to your specific biology.

1. Personalized Ovarian Stimulation

After 40, the standard "one-size-fits-all" stimulation protocol often underperforms. accredited partner fertility centers use individualized protocols based on your AMH (Anti-Müllerian Hormone) level, antral follicle count, and previous cycle response. For patients with diminished ovarian reserve, modified natural cycle or mini-IVF protocols may yield better quality eggs than aggressive high-dose stimulation.

2. PGT-A Genetic Screening

When 60-85% of your eggs may be aneuploid, knowing which embryos are chromosomally normal before transfer is transformative. PGT-A doesn't improve the per-egg success rate, but it dramatically improves the per-transfer success rate by ensuring you only transfer embryos with real potential. For women over 40, PGT-A-screened euploid embryos have implantation rates of 50-60% - equivalent to much younger patients.

3. AI-Assisted Embryo Selection

When combined with PGT-A, AI-powered time-lapse analysis adds another layer of selection precision - identifying not just which embryos are chromosomally normal, but which among the normal ones have the highest developmental quality and implantation probability.

4. Supplements and Lifestyle Optimization

Evidence-based interventions that may support egg quality include:

• CoQ10 (Ubiquinol): 400-600 mg daily. Supports mitochondrial function in eggs, which is critical for energy-intensive cell division. Best started 2-3 months before the IVF cycle.
• DHEA: 25 mg three times daily, under medical supervision. May improve ovarian response in women with diminished reserve. Requires monitoring of testosterone levels.
• Vitamin D: Optimal levels (40-60 ng/mL) are associated with better IVF outcomes according to Mayo Clinic.
• Mediterranean diet pattern: Rich in omega-3 fatty acids, antioxidants, and whole grains. Multiple studies associate this dietary pattern with improved egg quality and IVF success.
• Stress reduction: Chronic stress elevates cortisol, which can impair follicular development. Mindfulness, acupuncture, and psychological support have shown modest but meaningful benefits.

5. Embryo Banking

For patients over 40 with low egg retrieval numbers per cycle, embryo banking - performing multiple retrieval cycles and accumulating embryos before testing and transferring - can build a larger pool of embryos to screen, increasing the probability of finding at least one chromosomally normal embryo.

The Donor Egg Conversation

This is often the most emotionally charged part of the IVF-over-40 journey. And it deserves honest, compassionate discussion.

When you use donor eggs from a woman in her 20s, the success rate is approximately 50-60% per transfer - regardless of whether the recipient is 40, 45, or 50. This is because the uterus doesn't age in the same way ovaries do; a healthy uterus can successfully carry a pregnancy well into the late 40s (HFEA).

Donor eggs become a primary consideration when:

• Multiple own-egg cycles have failed despite good clinical protocols
• AMH is very low (under 0.5 ng/mL) with minimal antral follicles
• Patient age is 43+ and time for multiple own-egg attempts is limited
• The couple prioritizes maximizing pregnancy probability per cycle

At accredited partner fertility centers, donor egg programs are supported by rigorous medical screening, psychological counseling, and transparent matching processes - ensuring both donors and recipients are supported at every step. To weigh this path in depth, see our guide on IVF with donor eggs, and for the full clinical journey, our overview of IVF treatment steps.

Questions to Ask Your Fertility Specialist

A consultation after forty carries more weight than most, because the decisions that follow it are time-sensitive. Take these in writing, and write the answers down.

• Given my AMH, antral follicle count, and history, what would you realistically expect from a cycle?
• Which protocol are you proposing for me, and why that one rather than another?
• Would you expect enough embryos to make PGT-A worthwhile in my case?
• How many cycles would you suggest before we reconsider the whole approach?
• At what point would you raise donor eggs with me, and what would prompt that conversation?
• What are your outcomes for patients with my profile, and where are they published?
• If you were in my position, what would you do — and what would you not do?

IVF After 40 at Accredited Partner Centers

accredited partner fertility clinics are specifically equipped for age-related fertility challenges, offering:

• Advanced laboratory technology: Time-lapse incubators, AI embryo selection, and PGT-A capability as standard
• Individualized protocols: Stimulation plans tailored to diminished ovarian reserve, not adapted from younger-patient templates
• Comprehensive support: Fertility psychologists, nutritionists, and dedicated patient coordinators
• Transparent pricing: IVF packages with clear cost breakdowns set out in the written quote issued by the partner hospital
• Donor egg program: Fully screened, anonymous and identified donor options with ethical, compassionate matching

The most important thing a woman over 40 considering IVF can do is this: act now. Not impulsively - but decisively. Every month of delay after 40 represents a measurable decline in ovarian reserve. A consultation doesn't commit you to anything. But it gives you the data - your AMH, your AFC, your realistic prognosis - to make an informed, empowered decision on your own timeline.